Ranbaxy Sues FDA Over Nixed Approvals Of Generics
Ranbaxy Laboratories Ltd. sued the U.S. Food and Drug Administration in D.C. federal court on Friday over recently revoked tentative approvals for generic versions of AstraZeneca PLC's Nexium and Genentech Inc.'s...To view the full article, register now.
Already a subscriber? Click here to view full article